These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1528133)

  • 41. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns.
    Clisham PR; Cedars MI; Greendale G; Fu YS; Gambone J; Judd HL
    Obstet Gynecol; 1992 Feb; 79(2):196-201. PubMed ID: 1731285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2.
    Viinikka L; Orpana A; Puolakka J; Pyörälä T; Ylikorkala O
    Obstet Gynecol; 1997 Jan; 89(1):104-7. PubMed ID: 8990448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
    Gräser T; Koytchev R; Müller A; Oettel M
    Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spacing-out of progestin--efficacy, tolerability and compliance of two regimens for hormonal replacement in the late postmenopause.
    Rabe T; Mueck AO; Deuringer FU; Vladescú E; Runnebaum B
    Gynecol Endocrinol; 1997 Dec; 11(6):383-92. PubMed ID: 9476087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endometrial safety of a transdermal sequential estradiol-levonorgestrel combination.
    Sturdee DW; van de Weijer P; von Holst T
    Climacteric; 2002 Jun; 5(2):170-7. PubMed ID: 12051113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
    Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
    Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low dose continuous combined hormone replacement therapy: early and late postmenopausal effect on endometrium.
    Chantler IW; Davie MW
    J Ultrasound Med; 2000 Jan; 19(1):33-8. PubMed ID: 10625188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
    Kuhnz W; Heuner A; Hümpel M; Seifert W; Michaelis K
    Contraception; 1997 Dec; 56(6):379-85. PubMed ID: 9494772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of two HRT regimens with bimonthly and monthly progestin administration in postmenopause.
    De Leo V; la Marca A; Morgante G; Lanzetta D
    Maturitas; 1999 Jan; 31(2):171-7. PubMed ID: 10227012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium.
    Pansini F; De Paoli D; Albertazzi P; Bonaccorsi G; Campobasso C; Zanotti L; Pisati R; Giulini NA
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):137-41. PubMed ID: 8886696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    BJOG; 2005 Oct; 112(10):1402-6. PubMed ID: 16167944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined oral estradiol valerate-norethisterone treatment over three years in postmenopausal women. 1. Clinical aspects and endometrial histology.
    Perry W; Wiseman RA; Cullen NM
    Gynecol Endocrinol; 1998 Apr; 12(2):109-22. PubMed ID: 9610424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.
    Wiseman LR; McTavish D
    Drugs Aging; 1994 Mar; 4(3):238-56. PubMed ID: 8199397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
    al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
    Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.